A landmark investigation by Yamamoto and colleagues utilized a murine model of ataxia–telangiectasia (AT)—a condition marked by defective DNA repair due to mutations in the ATM gene—to examine microbiota-mediated modulation of lymphoma risk [28]. Here, ATM is linked to ataxia telangiectasia.